{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32657678", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2020", "Month": "07", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.7196/SAMJ.2020.v110i2.14410"], "Journal": {"ISSN": "2078-5135", "JournalIssue": {"Volume": "110", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "29"}}, "Title": "South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde", "ISOAbbreviation": "S Afr Med J"}, "ArticleTitle": "Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy.", "Pagination": {"StartPage": "102", "EndPage": "105", "MedlinePgn": "102-105"}, "Abstract": {"AbstractText": ["The compounds present in cannabis have been in use for both recreational and medicinal purposes for many centuries. Changes in the legislation in South Africa have led to an increase in the number of people interested in using these compounds for self-medication. Many of them may approach their general practitioner as the first source of information about possible therapeutic effects. It is important that medical professionals are able to give patients the correct information. Cannabidiol (CBD) is one of the main compounds in cannabis plants, and there is evidence that it can successfully treat certain patients with epilepsy. This review looks at the most recent evidence on the use of CBD in the treatment of epilepsy and explores the mechanisms behind these beneficial effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Sefako Makgatho Health Sciences University. Pretoria, South Africa. leon.hay@smu.ac.za."}], "LastName": "Hay", "ForeName": "L", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "South Africa", "MedlineTA": "S Afr Med J", "NlmUniqueID": "0404520"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Cannabidiol"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cannabis"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Epilepsy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "South Africa"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "1", "Day": "29"}, {"Year": "2020", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["32657678", "10.7196/SAMJ.2020.v110i2.14410"]}}]}